1. Effect of Recombinant or Lymphoblastoid Interferon-α on Alanine Aminotransferase in Patients with Chronic Hepatitis C or Chronic Non-A Non-B Hepatitis

   • F. Bardelli
   • A. Messori
   • N. Martini

   Clinical Use 25 October 2012 Pages: 239 - 254

2. Effects of Amlodipine on Platelet Aggregation in Hypertensive Patients

   • C. Rostagno
   • A. Colella
   • G. F. Gensini

   Clinical Pharmacodynamics 25 October 2012 Pages: 255 - 259

3. A Limited Sampling Model with Bayesian Estimation to Determine Inulin Pharmacokinetics Using the Population Data Modelling Program P-PHARM

   • Jean-Marie Kinowski
   • Françoise Bressolle
   • Roberto Gomeni

   Clinical Pharmacokinetics 25 October 2012 Pages: 260 - 269

4. Effect of Food on the Pharmacokinetics of Meloxicam after Oral Administration

   • D. Türck
   • U. Busch
   • G. Nehmiz

   Pharmacokinetics 25 October 2012 Pages: 270 - 276

5. A Randomised Study Comparing Digoxin and Propafenone in the Treatment of Recent Onset Atrial Fibrillation

   • Raffaele Baroffio
   • Guido Tisi
   • Pierluigi Annoni

   Clinical Use 25 October 2012 Pages: 277 - 283

6. Preliminary Trial of the Efficacy of Bucillamine in Korean Patients with Rheumatoid Arthritis

   • Seong Yoon Kim
   • In H. Lee
   • Dae H. Yoo

   Clinical Use 25 October 2012 Pages: 284 - 290

7. Placebo-Controlled Evaluation of the Efficacy and Tolerability of Permixon® in Benign Prostatic Hyperplasia after Exclusion of Placebo Responders

   • JL Descotes
   • JJ Rambeaud
   • G Faure

   Clinical Use 25 October 2012 Pages: 291 - 297

8. Electrophysiological Effects of Mexiletine on Atrial Vulnerability in Patients with Paroxysmal Atrial Fibrillation

   • Itsuki Omori
   • K. Furukawa
   • M. Nakagawa

   Short Communication 25 October 2012 Pages: 298 - 302